chrisvoncsefalvay/vaers-outcomes huggingface dataset:
BODY ACHES; WORSENED BACK PAIN; WORSENED NECK PAIN; FEVER; This spontaneous report received from a patient concerned a 66 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included neck pain, and back pain, and other pre-existing medical conditions included the patient had no known allergies and did not have any medical conditions.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 03-AUG-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 03-AUG-2021, the subject experienced fever. Laboratory data included: Body temperature (NR: not provided) 99.5 F. On 04-AUG-2021, the subject experienced body aches. On 04-AUG-2021, the subject experienced worsened back pain. On 04-AUG-2021, the subject experienced worsened neck pain. Laboratory data included: Body temperature (NR: not provided) 100.5 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fever, body aches, worsened back pain, and worsened neck pain. This report was non-serious.
got the nerve ending pain; I didn't get shingles; I got all the pain of shingles/it is just a little sore; imbibing the chickenpox virus in my body; I have croaky voice; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 78 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 21Jun2021 (Lot number: EW0178) at the age of 77 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "shingles", start date: 2020 (unspecified if ongoing), notes: I have had really bad case of shingles (later clarified) in the Nov and Dec last year. There were no concomitant medications. Vaccination history included: Covid-19 vaccine (Dose 1, Lot number: EW0178 , that's what on both of them.), administration date: 01Jun2021, when the patient was 77 years old, for COVID-19 Immunization. The following information was reported: NEURALGIA (non-serious) with onset 2021, outcome "recovered" (2021), described as "got the nerve ending pain"; PAIN (non-serious) with onset 2021, outcome "recovered" (2021), described as "I didn't get shingles; I got all the pain of shingles/it is just a little sore"; VARICELLA (non-serious) with onset 2021, outcome "recovered" (2021), described as "imbibing the chickenpox virus in my body"; DYSPHONIA (non-serious) with onset 2021, outcome "recovered", described as "I have croaky voice". The events "got the nerve ending pain", "i didn't get shingles; i got all the pain of shingles/it is just a little sore", "imbibing the chickenpox virus in my body" and "i have croaky voice" were evaluated at the physician office visit. Therapeutic measures were taken as a result of neuralgia, pain.  Additional information: Patient stated, this is happened to after got second injection. Patient had not shingles but patient got the nerve ending pain. Patient got all the pain of shingles for 2 and half weeks. Time of vaccination: May be between 4:30 and 5:00 clock. Start date of edverse events, it was probably thinking little may be 2, 3 4 days because patient had it for 2 and half weeks and I ended up going to patient doctor's. Patient still not experiencing, it lasted 2 and half weeks and it was gone. Patient went to the doctor, patient looked out it whatever patient husband and patient got whatever those patches are for pain and stuff like that we put on top of it so that I sleep at night.  Follow-up (22Dec2021): Follow-up attempts are completed. No further information is expected.
13AUG93 onset of blank staring episodes w/duration of few seconds to a few minutes; during these spells, pt appeared glassy eyed, not recognizing family members & occasionally fell to the floor; occurred 4-5x/hr from 6PM to 10PM;
Pt received Moderna vaccine and had a severe allerigic reaction and swelling of the lips. had to give epi pen
Presented to urgent care on 4/29 for left side numbness and tingling, got Pfizer dose in left shoulder. Patient suspected to have thoracic outlet syndrome as slight pressure over the scalene muscle and brachial plexus reproduces the symptoms that she is been having off and on for the last week. Patient's treatment plan consists of taking anti-inflammatories for the next several days, introduction of an oral steroid for the next 5 days to decrease any possible inflammation of the brachial plexus and the use of a muscle relaxer in the evening in the event she is having spasms along the shoulder muscles. Patient to RTC if signs and symptoms fail to resolve or worsen.
Left arm below elbow down to thumb get a fuzzy feeling about 20-25 times a day. Lasts about 30-60 seconds. It kind of feels like I feel all the hairs on my arm (not forearm)
patient complained of some slight chest discomfort 2 minutes after receiving vaccination. patient was examined and monitored to include physical exam, vital sign check and ECG all of which were normal. patient was kept in the office for monitoring  for 60 minutes and symptoms had subsided. she left the office without any evidence of distress and reported she felt better. She was also advised to seek medical attention if symptoms returned/persisted or worsened. injection site viewed and no signs of reaction.
COVID-19; COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient.  A 37-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 11Apr2021 as dose 1, single (Lot number: EW0150), in left arm and on 02May2021 as dose 2, single (Lot number: ER8735), in left arm for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), on 15Jan2022 as dose 3 (booster), single (Lot number: 008F21A), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing); "Acid reflux" (unspecified if ongoing); "Fibromyalgia" (unspecified if ongoing); "IBS" (unspecified if ongoing). Other medication in 2weeks: Concomitant medication(s) included: FLUOXETINE, start date: May2015. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19". Anti-viral details COVID 19 Treatment. Paxlovid Treatment start date: 13May2022. Treatment stop date: 14May2022. After 2nd Paxlovid dose, started seeing cloud-like shapes, which were moving and blurring vision. This occurred in right eye only but it impaired total vision. Reaction took place for 15-20 minutes. Therapeutic measures were taken as a result of vaccination failure, covid-19.  No follow-up attempts are possible. No further information is expected.
The patient was first seen at the clinic on Friday, 24 Jan 2003. At that time he had red eye OS onset 9 days after small pox vaccination. On exam, he had multiple, elongated oval infiltrates located in the anterior-to-mid stroma at the limbus inferonasally OS, similar to what might be seen with staph hypersensitivity. Although there was nasal conjunctival and circumlimbal injection, there were no lid or conj lesions such as vesicles or pustules, no epithelial keratitis, and no iritis. OD was uninvolved. Because of the timeframe of the onset of his symptoms, the patient was started on Viroptic for possible vaccinia keratitis and followed in 72 hours. On Monday 27 Jan. the inferonasal lesions were resolving, but he had new lesions temporally. The new lesions were similar to the first presentation, but located more anteriorly in the stroma. Again, there were no vesicles, pustules, and the epithelium was intact. The patient was continued Viroptic OS. On 30 Jan, the corneal lesions were largely resolved OS, though the conjunctive remained mildly-to-moderately injected (possibly as a result of the Viroptic). However, he now noted on awakening that he had redness and irritation of OD. On exam, he had several small pustular lesions at the inferior and nasal limbus. The stroma underlying the pustular lesions was clear, but he had anterior stromal infiltrates at the temporal limbus that were similar in appearance to those seen OS. As with the OS, there were no lid lesions, and no conjunctival lesions except focal injection nasally.  2 of the lesions were unroofed and specimens were sent for viral culture and PCR for vaccinia virus. The patient was continued Viroptic OS, and started it OD as well, for probable vaccinia keratitis.  The patients eye redness and corneal lesions resolved with Viroptic treatment.  The viral and PCR studies were negative for evidence of Vaccinia virus. He completed 2 weeks of Viroptic in the left eye (OS) and is clinically resolved. He is finishing his second week of Viroptic in the right eye (OD) and the corneal lesions have resolved. He has some minor redness of the conjunctiva, which is most likely due to the antiviral medication. Ophthalmology expects this to resolve once he is off all medications, and for him to make a full recovery without significant sequellae.
This spontaneous report was received from a nurse regarding an unknown age patients of unknown gender. The patient's medical history, concurrent conditions, concomitant medications and drug reactions/allergies were not provided. On an unknown date, unspecified patients were administered with an improperly stored dose of M-M-R II lot# reported as N01105 and 05-APR-2019 expiration date and lot# N00153 with 13-JAN-2019 expiration date for prophylaxis (strength, frequency and route of administration were not reported); LIQUID PEDVAXHIB lot#N016992 and 07-MAR-2020 expiration date for prophylaxis (strength, frequency and route of administration were not reported); PNEUMOVAX 23 lot# M042324 with 10-JUN-2018 expiration date for prophylaxis Pneumococcal Vaccine, Polyvalent (23-valent); RECOMBIVAX HB lot# reported as M02926 with 11-AUG-2019 expiration date for prophylaxis (strength, frequency and route of administration were not reported); ROTATEQ, orally, lot# N022174 with 16-MAR-2019 expiration date for prophylaxis (dose, strength and frequency were not reported); VAQTA lot#N030286 and 10-NOV-2018 expiration date for prophylaxis (strength, frequency and route of administration were not reported). Data logger was reported. The temperature excursion and time frame for both vaccines was between 9°C and 25°C for a cumulative time of 61 hours. No previous temperature excursion was present. No adverse event was reported. No product quality complain was present.
Pt. stated, "I felt tingling in my throat 14 minutes after getting vaccinated."  "It felt like the tingling I had when I got an allergic reaction to hydrocortisone."  Vital signs taken: B/P 110/70, O2Sat 99%, HR 88,  At 11:28am, pt. reported feeling better, tingling is going away.  At 11:32am pt. went home with husband.
Hives and facial swelling after 7 days. The evening of the injection, small patch of hives on face that went away, but returned in a few days.
VACCINATION IN (PRIVACY) WAY USING AN AIR GUN INSTEAD OF NEEDLE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient experienced vaccination in (privacy) way using an air gun instead of needle. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of vaccination in (privacy) way using an air gun instead of needle was not reported. This report was non-serious.
Blood sugar dropped very low and was very hard to bring back up. Blood sugar was in the 40s which is coma level for him, ate over 300 grams of sugar and his levels only went up to 70s. After a few hours his sugar levels finally went into the 200's.  Dizziness, vision loss which may be related to the very low blood sugar.  Zoned out for hours, memory fog, couldnt speak correctly/form sentences.
Atrial fibrillation; Feeling fluttery; Heart rate was racing and was increasing, went up to 175 just sitting; A spontaneous report was received from a consumer concerning a 64-year-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced atrial fibrillation, feeling fluttery, and heart rate was racing and was increasing, went up to 175 just sitting.  The patient's medical history was not provided. Concomitant medications included Travatan for glaucoma.    On 12 Feb 2021, prior to the onset of the events, the patient received the first of two planned doses of mRNA-1273 (lot/batch: 030M20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 12 Feb 2021, five hours after vaccination, the patient experienced a fluttery feeling, heart rate was racing and was increasing, heart rate went up to 175 just sitting. She took an EKG on her watch and it was atrial fibrillation. When she was sleeping, her heart rate was at 102 or the 90s, normally it would be in the 60s.    No treatment information was provided.   Action taken with mRNA-1273 in response to the events was not reported.  At the time of this report, the outcome of the events, atrial fibrillation, feeling fluttery, and heart rate was racing and was increasing, went up to 175 just sitting, was unknown.; Reporter's Comments: This case concerns a 64 year old female patient, who was on hospice care experienced a fatal event of death, 1 day after receiving second dose of mRNA- 1273 (Lot# 030M20A). Very limited information regarding this event has been provided at this time. Further information has been requested.
Adverse reaction after Moderna vaccine; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Adverse reaction after Moderna vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No relevant concomitant medications reported. No relevant medical history was reported.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Adverse reaction after Moderna vaccine). At the time of the report, VACCINATION COMPLICATION (Adverse reaction after Moderna vaccine) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Treatment Medications were not provided by the reporter.   Reporter did not allow further contact; Reporter's Comments: not specific adverse event reported
Patient has not reported any adverse event.; given booster bivalent booster after one dose of Pfizer; Inadvertently gave Bivalent booster dose to a patient who only had one dose of Pfizer vaccine; Revaccination with different COVID-19 vaccine; This spontaneous case was reported by a nurse and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (given booster bivalent booster after one dose of Pfizer), INTERCHANGE OF VACCINE PRODUCTS (Inadvertently gave Bivalent booster dose to a patient who only had one dose of Pfizer vaccine), COVID-19 IMMUNISATION (Revaccination with different COVID-19 vaccine) and NO ADVERSE EVENT (Patient has not reported any adverse event.) in a 64-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 021H22A) for COVID-19 prophylaxis.     Previously administered products included for Drug use for unknown indication: Pfizer vaccine on 08-Sep-2022. Past adverse reactions to the above products included No adverse reaction with Pfizer vaccine.    On 11-Nov-2022, the patient received second dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 11-Nov-2022, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (given booster bivalent booster after one dose of Pfizer), INTERCHANGE OF VACCINE PRODUCTS (Inadvertently gave Bivalent booster dose to a patient who only had one dose of Pfizer vaccine) and COVID-19 IMMUNISATION (Revaccination with different COVID-19 vaccine). On an unknown date, the patient experienced NO ADVERSE EVENT (Patient has not reported any adverse event.). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (given booster bivalent booster after one dose of Pfizer), INTERCHANGE OF VACCINE PRODUCTS (Inadvertently gave Bivalent booster dose to a patient who only had one dose of Pfizer vaccine), COVID-19 IMMUNISATION (Revaccination with different COVID-19 vaccine) and NO ADVERSE EVENT (Patient has not reported any adverse event.) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (Patient has not reported any adverse event.) to be not related. No further causality assessments were provided for INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (given booster bivalent booster after one dose of Pfizer), INTERCHANGE OF VACCINE PRODUCTS (Inadvertently gave Bivalent booster dose to a patient who only had one dose of Pfizer vaccine) and COVID-19 IMMUNISATION (Revaccination with different COVID-19 vaccine).    No concomitant medications were reported.  A nurse in their facility inadvertently gave the bivalent booster dose to a patient on 11-Nov-2022 who only had one dose of Pfizer vaccine (lot number not available, dose was given on 08-Sep-2022).  No treatment information was reported.
About 5 hours after the injection I started feeling tired and achy (around 6 PM). I went to bed early because I wasn't feeling any better. In the middle of the night I was achy had a slight fever and my skin felt prickly. I also had a headache. I took some ibuprofen. I got up at 5 AM to go to work and still had the same symptoms but my temperature was done to 99.9 degrees. I took more ibuprofen. I only worked 2.5 hours and had to leave work early. I went straight to bed at 9:15 AM. I woke up at noon and ate lunch, took another ibuprofen and went back to sleep. I woke up at 3:30 PM and only had a residual headache. The next day, 8/2/2018 I felt fine, just a sore arm. I was able to go to work.
Redness and swelling to arm around injection site. Since injection, patient has experienced cough, fever, fatigue. Mom states child has no energy, sleeps often.
Patient had anaphylactic reaction around at 6pm after getting 2nd vaccine (1st was also Pfizer) at 2pm, and went to hospital. According to patient she did not do anything different on that day other than getting a vaccine.
Pt developed swelling of thigh and painful knee following administration of vaccine (Pneumovax) to left thigh. Will follow up.
Developed hives on shoulders & thighs.  No lip/tongue swelling, 2 hours after vaccines administered.  Also on AMOXIL.  AMOXIL discontinued, BENADRYL 3/4 tsp q 6 hours.
Immunization administered 9:55 am. Received call from patient's wife 1:45pm reporting chills. Another call around 4:00pm reporting vomiting. I called to check on patient at 7:30pm. patient's wife stated symptoms improved, no more vomiting occurred. She feels he is better.
Approximately 2 hours after vaccination, she complained to co-workers about being dizzy and then she had a syncopal episode where she lost consciousness and had seizure like activity lasting approximately 1 minute. She was taken by EMS to the  Emergency Department and evaluated, here it was discovered that she has a history of nonepileptic seizure episodes and the Physician Assistant providing care did not think this episode was "measureable allergic reaction to her vaccination however perhaps the stress and worry of having this shot just prior to her symptoms".  Followed up with the employee today and she is having expected side effects from vaccine administration (body aches, fever up to 102-103, and headache), no further seizure like activity.
Information has been received from a physician concerning a 21 year old female who on an unknown date was vaccinated intramuscularly with the first dose of HPV rL1 6 11 16 18 VLP vaccine (yeast) (lot # not provided). Subsequently, the patient developed "swelling feet" for an unspecified amount of time after receiving the injection. At the time of this report the patient was recovering. Additional information has been requested.
Vaccine was administered 4 day beyond use date. When called patient to discuss that he reported that since receiving the vaccine he has been unable to  left his arm. Will call MD to report the reaction to MD.
Pt recvd 3 doses of Engerix-B 1NOV90, 7DEC90, & 9MAY91 & 27SEP91 it was determined that pts titer was neg p/3 doses of Engerix-B;
dizziness and to feel her body "different"; dizziness and to feel her body "different"; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 17Mar2021 (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: FEELING ABNORMAL (non-serious), DIZZINESS (non-serious) all with onset Mar2021, outcome "unknown" and all described as "dizziness and to feel her body "different".  Additional information: Patient received the vaccine on 17Mar and a week ago she started to feel dizziness and to feel her body "different". Referred to her physician for treatment recommendations.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient received a full 0.5ml dose instead of the 0.25ml booster dose.  This was his 4th Moderna dose (2nd booster).   Patient was contacted on Thursday, June 16th and made aware of the error.  No adverse effects noted from the patient.
Child fainted about 30 seconds after receiving vaccine. Child came to quickly and was given H2O and sugar. BP 110/68 P-68. Child had not eaten breakfast this am.
Very extreme pains throughout my whole body, extreme exhaustion, pain in lower part of stomach and pain when sitting.  Lasted for 3 days. Headach.
Numbness in Right Cheek; A spontaneous report was received from a Healthcare Professional concerning a 51-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events numbness in right cheek.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 1 Feb 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 027L20A) intramuscularly for prophylaxis of COVID-19 infection.   on an unknown date, patient experienced Numbness in Right Cheek.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   On an unknown date the outcome of events, numbness in right cheek was not reported.
A non-serious spontaneous report of arthritis in ankles manifested with inability to walk and rash has been received from a physician concerning a seven-year-old male, subsequent to FLUMIST. Neither the patient's past medical history nor the concomitant medications were reported. The patient received FLUMIST on 07-Sep-2011. On 08-Sep-2011, the patient developed rash and arthritis in both ankles, with inability to walk. The outcome of both the events was not recovered.
Shingles with neuritis on left leg shingles diagnosed clinically on 04/01/05. Varivax given on 04/19/00 given right arm. No family history of chicken pox disease.